PARTNER: Improving Patient and Family Centered Care in Advanced Critical Illness

Sponsor
University of Pittsburgh (Other)
Overall Status
Completed
CT.gov ID
NCT01844492
Collaborator
(none)
1,420
1
2
42.9
33.1

Study Details

Study Description

Brief Summary

One in five deaths in the U.S. occurs in or shortly after discharge from an intensive care unit (ICU), typically following decisions made by surrogate decision makers to forego life prolonging treatment. A large body of empirical research has identified deficiencies in care processes that contribute to three important problems: 1) family members often experience poor quality communication with ICU clinicians, leading to lasting psychological distress associated with the ICU experience; 2) patients near the end of life frequently receive invasive, expensive treatment that is inconsistent with their values and preferences, and 3) end-of-life care is a major contributor to health care costs.[8, 9] Although advance care planning can prevent some unwanted treatment, many patients wish for a trial of intensive treatment when the prognosis is uncertain, and therefore it seems likely that the need for interventions to improve "in-the-moment" decisions by surrogates will persist.[10, 11]

In a pilot project, the investigators developed the PARTNER intervention (PAiring Re-engineered ICU Teams with Nurse-driven Emotional Support and Relationship-building), an interdisciplinary intervention that 1) gives new responsibilities and advanced communication skills training to existing ICU staff (local nurse leaders and social work members of the ICU team); 2) changes care "defaults" to ensure frequent clinician-family meetings; and 3) adds protocolized, nurse-administered coaching and emotional support of surrogates before and during clinician-family meetings. The objective of this proposal is to conduct a stepped wedge randomized controlled trial testing the PARTNER intervention in 5 ICUs among 1000 patients with advanced critical illness and their surrogates.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: The PARTNER Intervention
  • Other: ICU Usual Care Control
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
1420 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Intervention Model Description:
Sample size listed is for patients (n=1420), for whom 809 surrogates completed long-term follow-upSample size listed is for patients (n=1420), for whom 809 surrogates completed long-term follow-up
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Improving Patient and Family Centered Care in Advanced Critical Illness
Actual Study Start Date :
Jul 23, 2012
Actual Primary Completion Date :
Feb 18, 2016
Actual Study Completion Date :
Feb 18, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: ICU Usual Care Control

described below

Other: ICU Usual Care Control
The control group will receive usual care, in which the frequency and content of clinician-family communication is determined by the clinical team according to their usual practice. No study ICU has a protocolized approach to family communication and instead clinicians determine the timing and frequency of communication with families. All sites have palliative care services.

Experimental: The PARTNER Intervention

described below

Behavioral: The PARTNER Intervention
The PARTNER intervention (PAiring Re-engineered ICU Teams with Nurse-driven Emotional Support and Relationship-building) consists of: 1) institution of a clinical pathway for family support overseen by ICU staff nurses; 2) advanced communication skills training for ICU staff nurses; 3) a multifaceted strategy to support implementation of the clinical pathway for family support.

Outcome Measures

Primary Outcome Measures

  1. Hospital Anxiety and Depression Scale [At 6 months]

    Symptom burden of anxiety and depression in family members in a telephone interview 6 months after enrollment using the validated 14-item Hospital Anxiety and Depression scale (HADS).

Secondary Outcome Measures

  1. Quality of Communication (QOC) scale [At 6 months]

    Quality of communication in family members in a telephone interview 6 months after enrollment using the validated19 item Quality of Communication Scale.

  2. Patient-and Family Centeredness of Care Scale [At 6 months]

    Patient and Family -Centeredness of Care, using the 12-item Patient-Perceived Patient-Centeredness of Care Scale (PPPC) adapted for use by surrogates.

  3. Intensive Care Unit Length of Stay [Participants will be followed for duration of ICU stay, an expected average of 21 days.]

    Intensive Care Unit length of stay as assessed by abstraction of this information from hospital administrative records.

  4. Total Hospitalization costs [Duration of hospital stay, an expected average of 4 weeks]

    Total hospitalization costs by aggregating each patient's total service specific costs, generated from hospital administrative records. We will stratify this analysis by the patient's vital status at hospital discharge.

  5. Impact of Events Scale of Care Scale [At 6 months]

    We will assess symptoms of post-traumatic stress in family members in a telephone interview 6 months after enrollment using the validated 22 item Impact of Events Scale.

Other Outcome Measures

  1. Mortality [At 6 months]

    Hospital mortality and 6-month mortality using hospital administrative records, and the 6-month follow-up with surrogates.

  2. Katz Activities of Daily Living Scale [At 6 months]

    Functional status of the patient using the validated Katz Activities of Daily Living Scale at 6 months.

  3. Hospital Length of Stay [Participants will be followed for duration of hosptial stay, an expected average of 4 weeks.]

    We will assess hospital length of stay.

  4. 6-month health care utilization [inclusive of index hospitalization and 6 months follow up]

    We will assess patient health care utilization using hospital records and through standardized interviews with surrogates at 6 months.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18 years of age or older

  • Surrogate decision maker for ICU patient in one of 5 UPMC ICU's

Exclusion Criteria:
  • Non-English Speaking

  • Surrogate's loved one is for organ transplantation

  • Not physically able to participate in family meeting

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Pittsburgh Medical Centers Pittsburgh Pennsylvania United States 15261

Sponsors and Collaborators

  • University of Pittsburgh

Investigators

  • Principal Investigator: Douglas B. White, MD,MAS, University of Pittsburgh

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Douglas White, MD, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT01844492
Other Study ID Numbers:
  • PRO13020304
First Posted:
May 1, 2013
Last Update Posted:
Mar 20, 2018
Last Verified:
Mar 1, 2018

Study Results

No Results Posted as of Mar 20, 2018